| Document Date: 2005-07-06 02:13:57
Open Document File Size: 55,67 KBShare Result on Facebook
City Directory / Amsterdam / / Company SSRI Limited / Pearson / BP / Cambridge University Press / Venlafaxine Limited / HP / HCA / / Country Australia / United Kingdom / Espana / / Currency pence / / / Facility Arch Gen Psychiatry / Pharmacy Department / Hall JM et al. / / IndustryTerm neurotransmitter systems / treatment of depression / treatment for depression / treatment of psychiatric illness / / MedicalCondition Insomnia / FLU DMI/IMI / SS=serotonin syndrome / resistant depression / FLU / seizures / psychiatric illness / dysfunction / treatment resistant depression / serotonin syndrome / obesity / Bazire S. Depression / refractory depression / delirium / resistant major depression / therapy resistant depression / depression / treatment-resistant depression / / MedicalTreatment electroconvulsive therapy / Polypharmacy / / Organization Cambridge University / Amsterdam JD / Pharmacy Department / / Person Kate Smith / Fluoxetine / Ann Clin / Mark Allen / Ann Pharmacother / / Position author / Open trial RCTs Carpenter / Governor / Joffe RT / Joffe RT / Kamil R et al / Carpenter / / Product venlafaxine / mirtazapine / fluoxetine / Tao / Yasmin / AMI / /
SocialTag |
Reboxetine – a ‘NaRI’ Clarify desipramine